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Objective. The objective of this study was to assess the utility of magnetic resonance enterography (MRE) compared with capsule
endoscopy (CE) for the detection of small-bowel polyps in patients with familial adenomatous polyposis (FAP). Methods. Patients
underwent MRE and CE. The polyps were classiﬁed according to size of polyp: <5mm (small size), 5–10mm (medium size),
or >10mm (large size). The location (jejunum or ileum) and the number of polyps (1–5, 6–20, >20) detected by CE were also
assessed. MRE ﬁndings were compared with the results of CE. Results. Small-bowel polyps, were detected by CE in 4 of the 6 (66%)
patients. Three patients had small-sized polyps and one patient had medium-sized polyps. CE detected polyps in four patients
that, were not shown on MRE. Desmoid tumors were detected on anterior abdominal wall by MRE. Conclusion. In patients with
FAP, CE can detect small-sized polyps in the small intestine not seen with MRE whereas MRE yields additional extraintestinal
information.
1.Introduction
Familial adenomatous polyposis (FAP) is a disease with
autosomaldominantinheritance.Itiscausedbyanalteration
of the FAP (APC) gene that is located on chromosome 5q21.
The syndrome is characterized by the presence of adeno-
matous polyps in the gastrointestinal tract, mainly in the
colon, rectum, and duodenum and is associated with 100%
risk of colorectal cancer [1–3]. Patients with FAP have a
cumulativelifetimeriskofover80%fordevelopingduodenal
adenomas, which are the precursor lesions for duodenal
adenocarcinoma. Consequently, these patients have a 4%
lifetime risk of periampullary or duodenal adenocarcinoma
[4, 5]. In order to minimize the complications of small-
bowel polyposis in FAP, upper endoscopy and small-bowel
radiographic surveillance are recommended [6].
There is little doubt that capsule endoscopy (CE) is the
best method to evaluate the entire small-bowel mucosa [7].
Studies have shown that CE is useful and safe surveillance of
jejunal-ilealpolypsinselectedpatientswithFAP[8, 9].How-
ever, capsule endoscopy has limitations including evidence
that size estimation and anatomic localization of polyps at
capsule endoscopy may be inaccurate even if experienced
readers review the examinations [10]. Furthermore, polyps
can be double-counted or missed altogether because of a
combination of retrograde peristalsis, rapid capsule tran-
sit, and limited video frame capture rate [11–14]. CE is
contraindicated in patients suspected of bowel stricture or
obstruction [15].
Magnetic resonance enterography (MRE) has proven
to be a reliable technique for the evaluation of mucosal
abnormalities. MRE could be an ideal imaging modality to
follow patients with FAP, being noninvasive, well tolerated,
and radiation-free [16–18].
The aim of this study was to prospectively assess CE and
MRE in the diagnostic work-up of patients with FAP.2 Gastroenterology Research and Practice
Table 1: Demographic, clinical, CE, and MRE ﬁndings of the patients.
No Age Sex Prior surgery CE polyps Jejunum Ileum MRE
1 M 51 Subtotal colectomy + ileorectal anastomosis 6–20/<5mm + + −
2 M2 2 N o >20/5–10mm + + −
3 M 31 Subtotal colectomy + ileorectal anastomosis 1–5/<5mm − + −
4 M 28 Subtotal colectomy + ileorectal anastomosis 0 −− −
5 F2 6 N o 0 −− −
6 M 44 Proctocolectomy − ileoanal pouch anastomosis 1/<5mm + −
MRE: MR enterography, CE: capsule endoscopy, A: anastomosis.
2.MaterialsandMethods
Six patients with FAP were prospectively recruited between
June 2010 and April 2011: ﬁve men and one woman (median
age, 39.6 years; age range, 22–51 years), and examined
by using CE and MRE. Patients excluded were those
with severe swallowing disorders, claustrophobia, implanted
cardiac pacemaker or other electronic devices, pregnant
women, patients with a clinical suspicion of small-bowel
obstruction/pseudoobstruction, strictures or ﬁstulas, and
children under 16 years old.
Experienced endoscopist (O. E.) reported all the videos.
The polyps were classiﬁed into 3 groups: <5mm, 5–10mm,
or >10mm. The location (jejunum or ileum) and the
number of polyps (1–5, 6–20, >20) detected by CE were also
assessed. The location of small-bowel polyps was estimated
by analyzing the CE transit time between pylorus passage
and pouch-ileostomy (ileorectal anastomosis or ileocecal
valve). The duodenum was designated to be the small bowel
visualized up to 2min after pylorus passage. The remaining
CE transit time was divided into three thirds of which the
upper two thirds were designated jejunum and the lower
third was presumed to be ileum.
All patients gave their written informed consent for CE
and MRE exams. The study was approved by the local
ethical committees. The procedures were performed in the
morning, after an overnight fast. Bowel preparation was
performed with 4L polyethylene glycol (PEG) solution given
15 hours before the procedure. CE was performed by using
the PillCam SB with the RAPID workstation and software
(Given Imaging Ltd, Yoqneam, Israel). Patients were allowed
to drink ﬂuids 2 hours after capsule ingestion and were
allowed a light meal 4 hours later. Data were recorded for
approximately 8 hours. After data sampling, the recorder
was disconnected, and all data were downloaded to the
workstation and analyzed on the following day.
2.1. MRE Technique. In all patients, MRE was also per-
formed within 2 weeks after CE in separate occasions.
Patients were asked to fast the night before the examination,
and bowel enema was not given for intestinal preparation.
1500mL oral contrast agent solution (containing 10 grams
of methylcellulose, 200mL PEG, and 1300mL water) was
prepared, homogenized, and administered for intestinal dis-
tention. Oral-contrast agent was ingested over a 30–45min
period, as permitted by patients’ tolerance and cooperation.
After drinking up the whole solution, 20mg of hyoscine-N-
butyl bromide (Buscopan, Boehringer Ingelheim, Germany)
was given intravenously to suppress bowel spasm and
motion, and then patients were taken to the MR suite.
All MRE studies were performed by using a 1.5
Tesla MR machine (Philips Intera Achieva, Best, The
Netherlands) by using a phased-array body coil in supine
position. After acquiring three-plane scout images, two-
dimensional (2D) turbo spin-echo (TSE) T2- weighted
(W), 2D-TSE-T1W images and three-dimensional (3D)
T1W (THRIVE) gradient-echo images were obtained.
After intravenous administration of gadoterate-meglumine
(0.1mmol/kg; Dotarem, Guerbet, France), T1W sequences
were repeated with same parameters in portal and delayed
phases. MRE reported by one radiologist (O. A.).
3. Results
Of the 6 FAP patients, 3 had previously undergone a
proctocolectomy with ileoanal pouch anastomosis, 1 had a
subtotal colectomy with ileorectal anastomosis, and 2 had
no surgery. Patient demographics, prior operative history,
and a summary of CE and MRE ﬁndings are outlined in
Table 1. All patients successfully underwent MRE and CE.
Complete passage of the small bowel by CE was obtained in
all patients who performed CEs. No complications related to
capsule endoscopy or MRE were observed in any of the study
patients. Patients tolerated both methods. Image quality was
satisfactory in all patients.
Small-bowel polyps were detected by CE in 4 of the 6
(66%) FAP patients ranging from estimated <5mm to 5–
10mm in size (Table 1). Thereof, in three patients small-
sized (<5) and in one patient, medium-sized (5–10mm)
polyps were seen (Figures 1(a) and 1(b)). CE detected polyps
in four patients that were not shown on MRE. In one patient
(number 3) MRE showed two desmoids tumors, one of them
62 × 59mm in midabdominal area invading into the left
rectus muscle and the other 43 × 38mm extending from
anterior abdominal wall to subcutaneous tissue (Figures
2(a)–2(f)). These tumors were excised.
4. Discussion
FAP is a hereditary polyposis syndrome with a high risk for
benign small-bowel polyps and cancer. Hence, endoscopicGastroenterology Research and Practice 3
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Figure 1: CE detected small-sized (<5) (a) and medium-sized (5–10mm) (b) polyps.
surveillance of the upper gastrointestinal tract with forward-
viewing and lateral-viewing endoscopy, as well as ileoscopy,
is recommended [8, 19]. Upper gastrointestinal lateral-
viewing endoscopy is highly eﬀective for identifying most
polyps within the duodenum. However the possibility of
adenomas developing in segments of the bowel inaccessible
by standard upper GI endoscopy in a proportion of FAP
patients indicates that additional modes of screening could
be considered. Small-intestinal adenomas prevalence in FAP
patients varies, depending of the modality used for their
detection [20].
CE and MRE have both emerged relatively recently
and are increasingly utilized for small-bowel assessment.
Technical advances have enhanced MRE’s diagnostic capa-
bility in small-bowel imaging. CE is noninvasive, safe, and
comfortable and can be performed on an ambulatory basis
in FAP patients. Recently, CE has been shown to be eﬀective
for the detection of small-bowel polyps [8, 9].
A few previous studies already assessed the diagnostic
value of MRE in the evaluation of patients with FAP, in
comparison with capsule endoscopy, with preliminary sat-
isfactory results [17, 18]. In a study investigating diagnostic
value of MRE in the Peutz-Jeghers syndrome (PJS), this
method showed 93% concordance with enteroscopy [21].
The authors concluded that MRE could be used for surveil-
lance of PJS patients. Caspari et al. compared CE and MRE
for detection of small-intestinal polyps. Polyps larger than
15mm were equally detected by the two methods. However,
smaller lesions were better shown by CE [17]. Tescher et al.
also reached similar results in a study of 20 FAP cases [19].
In patients with FAP, CE can detect small-sized polyps
in the small intestine not seen with MRE whereas MRE
yields additional extraintestinal information. Probably, CE-
detected polyps in our study were not seen by MRE as they
were smaller than 15mm. Small-intestinal air-ﬂuid levels
might have masked the polyps in MRE. Also, insuﬃcient
small-intestinal distention might have obscured them. CE
may be more valuable in detection of small polyps as it
shows the mucosa directly. Due to the small size of the
detected polyps in this series, no histology was obtained
and no polypectomy was performed. There is no suﬃcient
data concerning clinical relevance of these small-intestinal
polyps in FAP patients and necessity for surveillance yet.
Further studies are warranted. Gupta et al. compared CE to
MRE in 19 PJS patients. The two methods showed similar
performance in detection of the polyps of 10 to 15mm.
However, MRE was more eﬀective in recognition of those
larger than 15mm [18]. Such a comparison was not made
i no u rs t u d yd u et ol o wp a t i e n t .
OneofthelimitingfeaturesofCEisthatitmaynotdetect
periampullary lesions well. In a study of patients undergoing
CE for various reasons, Clarke et al. found 10.4% sensitivity
of CE in showing the major papilla [22]. Duodenal polyps
are usually adenomatous and have a 4–12% cancer risk
[19]. Therefore, side vision endoscopy is recommended for
visualization of periampullary region in FAP patients [22].
Studies investigating the value of MRE in imaging of the 2nd
part of duodenum may be planned.
FAP is a multisystem disorder of growth. Aﬀected indi-
viduals can develop thyroid and pancreatic cancer, hepato-
blastomas, CNS tumors (especially medulloblastomas), and
various benign tumors such as adrenal adenomas, osteomas,
desmoid tumors, and dental abnormalities. Prophylactic co-
lectomy has improved the life expectancy of patients, as a
result of which the prevalence of other manifestations has
increased [23]. In our study population, MRE showed des-
moid, tumors in one patient, and they were surgically re-
moved. MRE may be useful in detection of extraintestinal le-
sions in FAP patients. CE only gives the possibility of inves-
tigating intraluminal space and mucosa. On the other hand
MRE is able to show all layers of the small intestine and it
allowsidentiﬁcationofextraluminalpathologies,too[24].In4 Gastroenterology Research and Practice
(a) (b) (c)
(d) (e) (f)
Figure 2:MRenterographicimagesofthepatient3.Oncoronalfat-saturatedT2-weighted(W)HASTE(a),(b),T1W(c),(d),andcontrast-
material-enhanced T1W (e), (f), images show the desmoid tumors (thick arrows: inguinal desmoid tumor; thin arrows: mesenteric desmoid
tumor). The relationship between contrast-material-enhanced mesenteric desmoid tumor and small-bowel loops is clearly seen on the MR
images (arrow, (e)).
this aspect, MRE may be more advantageous than CE in FAP
patients.
In conclusion, both CE and MRE can be used for
screening the small bowel in patients with FAP. CE is
capable of detecting smaller polyps which can be missed
by MRE. However, MRE is superior for detecting larger
polyps with additional advantage of a rapid overview on
mural, perienteric, and extraenteric information. There is no
recent data concerning the clinical signiﬁcance of detection
of such small polyps. MRE might be the ideal modality for
surveillance for this reason. Therefore, further studies are
needed to clarify this matter.
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